Notice2024-13766
Agency Information Collection Activities: Proposed Collection; Comment Request
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 24, 2024
Issuing agencies
Health and Human Services DepartmentSubstance Abuse and Mental Health Services Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 121 (Monday, June 24, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 121 (Monday, June 24, 2024)]
[Notices]
[Pages 52483-52484]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-13766]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed project
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer at (240) 276-0166.
Comments are invited on: (a) whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Project: State Opioid Response (SOR)/Tribal Opioid Response (TOR)
Program Instrument (OMB No. 0930-0384)--Revision
SAMHSA is requesting approval to modify its existing SOR/TOR
Program Instrument by (1) broadening language from `naloxone' to
`naloxone and other opioid overdose reversal medications' due to the
availability of new FDA-approved non-naloxone overdose reversal
medications; (2) broadening language from `fentanyl test strips' to
`drug checking technologies as directed by SAMHSA' due to the
availability of new drug checking technology, including test strips for
other emerging substances; (3) reducing the number of questions from 12
to 10 by combining four questions with similar themes into two
questions for clarity; (4) removing question 12 because it is comprised
of more than one question with several different ideas, making it
unsuited for this instrument; and (5) adding one question at the
request of Office of National Drug Control Policy (ONDCP)to collect
information on Congressionally mandated and programmatic activities and
comply with reporting requirements. The program-level information is
collected quarterly and entered and stored in SAMHSA's Performance
Accountability and Reporting System, which is a real-time, performance
management system that captures information on SAMHSA funded substance
use and substance use disorder prevention, harm reduction, treatment,
and recovery support services, and mental health services delivered in
the United States. Continued approval of this information collection
will allow SAMHSA to continue to meet Government Performance and
Results Modernization Act (GPRA) of 2010 reporting requirements that
quantify the effects and accomplishments of its discretionary grant
programs.
The SOR/TOR programs are authorized under the Consolidated
Appropriations Act, 2023, Division H, Title II [Pub. L. 117-328], and
section 1003 of the 21st Century Cures Act [Pub. L. 114-255] (42 U.S.C.
290ee-3a), as amended. SOR/TOR programs aim to address the opioid
crisis by increasing access to FDA-approved medications for the
treatment of opioid use disorder (MOUD), and support the continuum of
prevention, harm reduction, treatment, and recovery support services
for opioid use disorder (OUD) and other concurrent substance use
disorders. The SOR program also supports the continuum of care for
stimulant misuse and use disorders, including for cocaine and
methamphetamine.
SAMHSA is proposing to revise the SOR/TOR Program Instrument data
collection instrument (OMB No. 0930-0384), to collect information on
Congressionally mandated and programmatic activities and comply with
reporting requirements.
SAMHSA developed the SOR/TOR Program Instrument to collect minimum
data on naloxone purchase and distribution, but the SOR/TOR programs
are unique in that they have prevention, education, and harm reduction
requirements. SOR/TOR grantees are required to engage in the following
prevention and education activities: (1) train peers, first responders,
and other key community sectors on recognition of opioid overdose and
appropriate use of the opioid overdose antidote naloxone; (2) develop
evidence-based community prevention efforts such as strategic messaging
on the consequences of opioid and stimulant misuse; (3) implement
school-based prevention programs and outreach; and (4) purchase and
distribute opioid overdose antidote reversal naloxone based on the
[[Page 52484]]
naloxone distribution and saturation plan, and train on its use. The
revised tool will continue to allow SAMHSA to collect data on the
required education and prevention activities, and better assess grantee
performance on these activities. The revisions will continue to assist
SAMHSA in providing comprehensive data on the full range of required
activities to inform Congressionally mandated reports for the SOR
program.
In order to address these issues, SAMHSA is proposing to (1)
broaden language from `naloxone' to `naloxone and other opioid overdose
reversal medications' due to the availability of new FDA-approved non-
naloxone overdose reversal medications; (2) broaden language from
`fentanyl test strips' to `drug checking technologies as directed by
SAMHSA' due to the availability of new drug checking technology,
including test strips for other emerging substances; (3) reduce the
number of questions from 12 to 10 by combining four questions with
similar themes into two questions for clarity; (4) remove question 12
because it is comprised of more than one question with several
different ideas, making it unsuited for this instrument; and (5) add
one question at the request of ONDCP to collect information on
Congressionally mandated and programmatic activities and comply with
reporting requirements.
A summary of the proposed changes includes:
<bullet> Broadening the language to include new medications and
technologies that will provide SAMHSA data on the following:
[cir] Purchase and distribution of naloxone and other opioid
overdose reversal medications; and
[cir] Purchase and distribution of drug checking technologies as
directed by SAMHSA.
<bullet> The revised tool will provide SAMHSA with clarification on
individuals recognizing an opioid overdose and appropriate use of
naloxone and other opioid overdose reversal medication by collapsing
two questions with a similar theme.
<bullet> The revised tool will provide SAMHSA with clarification on
individuals educated on the consequences of opioid and/or stimulant
misuse by collapsing two questions with a similar theme.
<bullet> One question will be added to provide data on the
following:
[cir] Types of entities that distribute naloxone and other opioid
overdose reversal medications.
The Center for Substance Abuse Treatment (CSAT) anticipates that
the time required to collect and report the program-level information
is approximately 18 minutes per response. Since the submission of the
previous OMB package, there has been an increase in the number of
respondents. The estimated burden associated with the program-level
instrument includes an adjustment to reflect the current number of
grantees.
Table 1--Estimate of Annualized Hour Burden for SOR/TOR Grantees
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Burden hours Total burden Hourly wage Total wage
SAMHSA data collection respondents respondent of responses per response hours \1\ cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
Grantee-Level Instrument................ 189 4 756 .30 226.80 $28.89 $6,552.25
---------------------------------------------------------------------------------------------------------------
CSAT Total.......................... 189 4 756 .30 226.80 28.89 6,552.25
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ The hourly wage estimate is $28.89 based on the Occupational Employment and Wages, Mean Hourly Wage Rate for 21-1018 Substance Abuse, Behavioral
Disorder, and Mental Health Counselors = $28.89/hr. as of May 2023 (<a href="https://www.bls.gov/oes/current/oes211018.htm">https://www.bls.gov/oes/current/oes211018.htm</a>. Accessed on April 17, 2024.)
Send comments to the SAMHSA Reports Clearance Officer, 5600 Fishers
Lane, Room 15E45, Rockville, Maryland 20857, OR email a copy to
<a href="/cdn-cgi/l/email-protection#1f6c7e72776c7e6f6d7e5f6c7e72776c7e3177776c31787069"><span class="__cf_email__" data-cfemail="7f0c1e12170c1e0f0d1e3f0c1e12170c1e5117170c51181009">[email protected]</span></a>. Written comments should be received by August
23, 2024.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024-13766 Filed 6-21-24; 8:45 am]
BILLING CODE 4162-20-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 24, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.